A study by Cang et al. confirmed that PEITC can be used as a histone deacetylase (HDAC) inhibitor in various tumors (e.g., prostate cancer, breast cancer, leukemia, and myeloma cells) [5]. The gene discussed is HDAC9; the disease is Familial prostate cancer.